In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cabaseril Drug Master File in Korea (Cabaseril KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cabaseril. The MFDS reviews the Cabaseril KDMF as part of the drug registration process and uses the information provided in the Cabaseril KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cabaseril KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cabaseril API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cabaseril suppliers with KDMF on PharmaCompass.